Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina Becker

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Immunology|February 21, 2024
Effects of serial radon spa therapy on pain and peripheral immune status in patients suffering from musculoskeletal disorders- results from a prospective, randomized, placebo-controlled trialAnna-Jasmina Donaubauer, Ina Becker, Gerhart Klein, et al.
Frontiers in Immunology|February 24, 2022
Corrigendum: Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 TrialAnna-Jasmina Donaubauer, Ina Becker, Thomas Weissmann, et al.
Frontiers in Immunology|October 29, 2021
Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 TrialAnna-Jasmina Donaubauer, Ina Becker, Thomas Weissmann, et al.
Frontiers in Immunology|May 23, 2022
Modulation of Differentiation and Bone Resorbing Activity of Human (Pre-) Osteoclasts After X-Ray ExposureDenise Eckert, Felicitas Rapp, Ayele Taddese Tsedeke, et al.
Journal for Immunotherapy of Cancer|February 17, 2021
Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitorsJian-Guo Zhou, Anna-Jasmina Donaubauer, Benjamin Frey, et al.
The Journal of Investigative Dermatology|January 1, 2022
Transcriptomes of MPO-Deficient Patients with Generalized Pustular Psoriasis Reveals Expansion of CD4<sup>+</sup> Cytotoxic T Cells and an Involvement of the Complement SystemStefan Haskamp, Benjamin Frey, Ina Becker, et al.
Journal of the American Chemical Society|September 29, 2023
3D-Shaped Binders of Unfolded Proteins Inducing Cancer Cell-Specific Endoplasmic Reticulum Stress In Vitro and In VivoInsa Klemt, Oleg Varzatskii, Roman Selin, et al.
Journal for Immunotherapy of Cancer|October 7, 2020
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8Markus Hecht, Antoniu Oreste Gostian, Markus Eckstein, et al.
Neoplasia (New York, N.Y.)|January 17, 2024
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trialMarkus Hecht, Benjamin Frey, Udo S Gaipl, et al.
Journal for Immunotherapy of Cancer|January 26, 2022
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancerMarkus Hecht, Markus Eckstein, Sandra Rutzner, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Immunology|February 21, 2024
Effects of serial radon spa therapy on pain and peripheral immune status in patients suffering from musculoskeletal disorders- results from a prospective, randomized, placebo-controlled trialAnna-Jasmina Donaubauer, Ina Becker, Gerhart Klein, et al.
Frontiers in Immunology|February 24, 2022
Corrigendum: Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 TrialAnna-Jasmina Donaubauer, Ina Becker, Thomas Weissmann, et al.
Frontiers in Immunology|October 29, 2021
Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 TrialAnna-Jasmina Donaubauer, Ina Becker, Thomas Weissmann, et al.
Frontiers in Immunology|May 23, 2022
Modulation of Differentiation and Bone Resorbing Activity of Human (Pre-) Osteoclasts After X-Ray ExposureDenise Eckert, Felicitas Rapp, Ayele Taddese Tsedeke, et al.
Journal for Immunotherapy of Cancer|February 17, 2021
Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitorsJian-Guo Zhou, Anna-Jasmina Donaubauer, Benjamin Frey, et al.
The Journal of Investigative Dermatology|January 1, 2022
Transcriptomes of MPO-Deficient Patients with Generalized Pustular Psoriasis Reveals Expansion of CD4<sup>+</sup> Cytotoxic T Cells and an Involvement of the Complement SystemStefan Haskamp, Benjamin Frey, Ina Becker, et al.
Journal of the American Chemical Society|September 29, 2023
3D-Shaped Binders of Unfolded Proteins Inducing Cancer Cell-Specific Endoplasmic Reticulum Stress In Vitro and In VivoInsa Klemt, Oleg Varzatskii, Roman Selin, et al.
Journal for Immunotherapy of Cancer|October 7, 2020
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8Markus Hecht, Antoniu Oreste Gostian, Markus Eckstein, et al.
Neoplasia (New York, N.Y.)|January 17, 2024
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trialMarkus Hecht, Benjamin Frey, Udo S Gaipl, et al.
Journal for Immunotherapy of Cancer|January 26, 2022
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancerMarkus Hecht, Markus Eckstein, Sandra Rutzner, et al.
Pageof 2